-
-
-
-
-
-
-
Citizens Reiterates Market Outperform Rating on Solid Biosciences (SLDB)
-
-
-
-
-
-
-
Solid Biosciences receives FDA orphan drug status for gene therapy SGT-212
-
-
-
-
-
-
-
Solid Biosciences gains UK Innovation Passport for Duchenne gene therapy
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Misses Q2 EPS by 42c
-
-
-
-
-
-
-
Citi Starts Solid Biosciences (SLDB) at Buy
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Misses Q1 EPS by 59c
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Solid Biosciences (SLDB)
-
413,069 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

